Effects of the number of neoadjuvant therapy cycles on clinical outcomes, safety, and survival in patients with metastatic colorectal cancer undergoing metastasectomy-Reference-Cited by-同舟云学术

Effects of the number of neoadjuvant therapy cycles on clinical outcomes, safety, and survival in patients with metastatic colorectal cancer undergoing metastasectomy

Published:2022 Issue:2 Volume:30 Page:65-76
ISSN:1555-3906
Container-title:Oncology Research
language:en
Short-container-title:OR

Author:

YEH YUNG-SUNG

Publisher

Computers, Materials and Continua (Tech Science Press)

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.techscience.com/or/v30n2/51228/pdf

Reference28 articles.

1. Neoadjuvant chemotherapy for colorectal liver metastases: A contemporary review of the literature;Guo;World Journal of Gastrointestinal Oncology,2021

2. Cancer statistics, 2022;Siegel;CA: A Cancer Journal for Clinicians,2022

3. Colon cancer, version 2. 2021, NCCN clinical practice guidelines in oncology;Benson;Journal of the National Comprehensive Cancer Network,2021

4. Pulmonary resection for metastases from colorectal cancer: Prognostic factors and survival;Lee;International Journal of Colorectal Disease,2007

5. Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis;Hayashi;BMC Surgery,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival Benefits of Asymptomatic Primary Tumor Resection After Bevacizumab Plus FOLFIRI as First-Line Therapy for Patients with Metastatic Colorectal Cancer with Synchronous Unresectable Metastasis;2024-07-16

2. Efficacy of transarterial chemoembolization with drug-eluting beads combined with systemic chemotherapy and targeted therapy in colorectal cancer liver metastasis;World Journal of Surgical Oncology;2023-12-01

3. Investigation of catalytic activity of metal doped nanocages (Ni-C72 and Ni-Al36P36) for ozone decomposition to oxygen molecules;Journal of Molecular Modeling;2023-08-04

4. The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: a noninterventional, uncontrolled multicenter study;British Journal of Cancer;2023-07-24

5. Efficacy and Safety of a Parenteral Nutrition Program for Patients with RAS Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study;Nutrients;2023-06-30